Neurocrine Biosciences, Inc <NBIX.O>: Leerink Partners raises target price to $210 from $170
NBIX•Related News
Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026
SRRK•
Trump says will be hitting Pickaxe Mountain area 'pretty soon'
SPY•
Europe Gasoline/Naphtha-Gasoline refining margins fall
XLE•
Non-competitive bids for U.S. 6-week bills
TLT•
Cushman & Wakefield names Chris Sonne executive director in valuation advisory return
CWK•